Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
25.68
+0.84 (3.38%)
At close: Jun 18, 2026, 4:00 PM EDT
25.75
+0.07 (0.27%)
After-hours: Jun 18, 2026, 4:14 PM EDT
Maze Therapeutics Employees
Maze Therapeutics had 141 employees as of December 31, 2025. The number of employees increased by 16 or 12.80% compared to the previous year.
Employees
141
Change (1Y)
16
Growth (1Y)
12.80%
Revenue / Employee
$141,844
Profits / Employee
-$869,092
Market Cap
1.42B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 141 | 16 | 12.80% |
| Dec 31, 2024 | 125 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 678 |
| Ardelyx | 489 |
| Maravai LifeSciences Holdings | 416 |
| MoonLake Immunotherapeutics | 130 |
| Inhibrx Biosciences | 110 |
| ArriVent BioPharma | 77 |
| GH Research | 73 |
| Savara | 70 |
MAZE News
- 9 days ago - Maze Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 11 days ago - Maze Therapeutics Transcript: AGM 2026 - Transcripts
- 16 days ago - Maze Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 16 days ago - Maze Therapeutics Slides: Investor presentation - Filings
- 23 days ago - Maze Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Maze Therapeutics reports Q1 EPS (45c), consensus (63c) - TheFly
- 5 weeks ago - Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights - GlobeNewsWire
- 5 weeks ago - Maze Therapeutics Earnings release: Q1 2026 - Filings